Results 171 to 180 of about 343,032 (304)
Impacts of wild blueberries on weight regulation, appetite, and cardiometabolic biomarkers of adults: A randomized clinical trial. [PDF]
Kern M +5 more
europepmc +1 more source
Kaplan–Meier hypertension‐free survival by baseline body mass index category, primary adult cohort (men aged ≥ 18 years, n = 12,742). Time since baseline in years is plotted on the horizontal axis and the probability of remaining free of treated hypertension is plotted on the vertical axis. Numbers at risk are shown beneath the plot.
Ebenezer Afrifa‐Yamoah
wiley +1 more source
Fredrick Atwiine, Albert Mwesigwa, Derick Mwesiga, Polly Mwesigwa, Lawrence Katumba, Patrick Engeu Ogwang Department of Pharmacy, Mbarara University of Science and Technology, Mbarara, UgandaCorrespondence: Fredrick Atwiine, Mbarara University of Science
Atwiine F +5 more
doaj
PRISMA 2020 flow diagram of included studies. ABSTRACT Purpose Immune checkpoint inhibitors have transformed treatment strategies for metastatic non‐small cell lung cancer (mNSCLC). This study aimed to assess the efficacy and safety of durvalumab combined with tremelimumab compared with those of standard chemotherapy, particularly in patients with low ...
Ikhwan Rinaldi +2 more
wiley +1 more source
Gustatory dysfunction under talquetamab therapy in multiple myeloma: a cross-sectional study of patient-reported course, nutritional changes, and quality of life. [PDF]
Fleischer A +13 more
europepmc +1 more source
The Impact of Glycation on Protein Digestibility
Schematic overview of how protein glycation affects digestibility and downstream nutritional consequences. Glycation‐derived structural modifications reduce protease accessibility, leading to limited hydrolysis and altered peptide generation. These changes decrease amino acid bioavailability and may subsequently contribute to microbiome alterations ...
Lea Hönemann +2 more
wiley +1 more source
Dietary protein content and its impact on amino acid profile and appetite in patients with methylmalonic acidemia. [PDF]
Köse E +4 more
europepmc +1 more source
Cofetuzumab pelidotin (Cofe‐P) is an anti‐protein tyrosine kinase 7 (PTK7) antibody‐drug conjugate (ADC) being investigated for the treatment of adults with PTK7‐expressing, recurrent non‐small cell lung cancer (NSCLC). The first‐in‐human (FIH) trial demonstrated tolerability of dosages ≤ 2.8 mg/kg once every 3 weeks (Q3W) and ≤ 3.2 mg/kg Q2W ...
Carla Biesdorf +8 more
wiley +1 more source
Insufficient dietary intake and symptom burden are associated with early nutritional decline in hospitalized patients with cancer. [PDF]
Soares CH +4 more
europepmc +1 more source
Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit +6 more
wiley +1 more source

